Henry SP - Search Results

1

Impurity Qualification Toxicology Study for a 2'-O-Methoxyethyl-Modified Antisense Inhibitor in Mice.

Kim TW, Papagiannis C, Capaldi D, McPherson AK, Mahdi F, Luu N, Rodriguez AA, Hoffmaster C, Serota D, Henry SP. Kim TW, et al. Among authors: henry sp. Nucleic Acid Ther. 2020 Feb;30(1):14-21. doi: 10.1089/nat.2019.0780. Epub 2019 Nov 5. Nucleic Acid Ther. 2020. PMID: 31687889

2

An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice.

Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby HI. Bennett CF, et al. J Pharmacol Exp Ther. 1997 Feb;280(2):988-1000. J Pharmacol Exp Ther. 1997. PMID: 9023316

3

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice.

Henry SP, Taylor J, Midgley L, Levin AA, Kornbrust DJ. Henry SP, et al. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):473-81. doi: 10.1089/oli.1.1997.7.473. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361906

4

Inhibition of coagulation by a phosphorothioate oligonucleotide.

Henry SP, Novotny W, Leeds J, Auletta C, Kornbrust DJ. Henry SP, et al. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):503-10. doi: 10.1089/oli.1.1997.7.503. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361909

5

Chemically modified oligonucleotides exhibit decreased immune stimulation in mice.

Henry S, Stecker K, Brooks D, Monteith D, Conklin B, Bennett CF. Henry S, et al. J Pharmacol Exp Ther. 2000 Feb;292(2):468-79. J Pharmacol Exp Ther. 2000. PMID: 10640282

6

Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.

Geary RS, Yu RZ, Watanabe T, Henry SP, Hardee GE, Chappell A, Matson J, Sasmor H, Cummins L, Levin AA. Geary RS, et al. Among authors: henry sp. Drug Metab Dispos. 2003 Nov;31(11):1419-28. doi: 10.1124/dmd.31.11.1419. Drug Metab Dispos. 2003. PMID: 14570775

7

Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in mice.

Henry SP, Denny KH, Templin MV, Yu RZ, Levin AA. Henry SP, et al. Birth Defects Res B Dev Reprod Toxicol. 2004 Dec;71(6):359-67. doi: 10.1002/bdrb.20023. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15617021

8

Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits.

Henry SP, Denny KH, Templin MV, Yu RZ, Levin AA. Henry SP, et al. Birth Defects Res B Dev Reprod Toxicol. 2004 Dec;71(6):368-73. doi: 10.1002/bdrb.20024. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15617022

9

Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.

Senn JJ, Burel S, Henry SP. Senn JJ, et al. Among authors: henry sp. J Pharmacol Exp Ther. 2005 Sep;314(3):972-9. doi: 10.1124/jpet.105.084004. Epub 2005 May 26. J Pharmacol Exp Ther. 2005. PMID: 15919763 Free article.

10

Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys.

Younis HS, Crosby J, Huh JI, Lee HS, Rime S, Monia B, Henry SP. Younis HS, et al. Among authors: henry sp. Blood. 2012 Mar 8;119(10):2401-8. doi: 10.1182/blood-2011-10-387134. Epub 2012 Jan 13. Blood. 2012. PMID: 22246038 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters